Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefuroxime and Tetracycline Bismuth Quadruple Therapy for H. pylori in Penicillin-Allergic Patients
NCT06351891Phase 4Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Apr 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tetracycline in Helicobacter pylori infection, sponsored by Qilu Hospital of Shandong University. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
tetracycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06351891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06351891.